The chief executive of Emergent BioSolutions Inc. (NYSE: EBS) has stepped down. Bob Kramer, Emergent’s president and CEO since spring 2019 and a longtime executive with the Gaithersburg biotech, notified its board of directors Friday he would be retiring from his positions the next day, according to documents filed with the Securities and Exchange Commission. Kramer intends to stay on as an adviser to the company until Aug. 1.
Emergent BioSolutions CEO Bob Kramer steps down, adviser named interim replacement
June 28, 2023